Gefitinib/osimertinibDrug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1764卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65570-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：146 / 146

相关论文

共 50 条

[21] Erlotinib/gefitinib/osimertinibDrug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1948 (1) : 199 - 199
[22] Cisplatin/osimertinibDrug resistance and nausea: case report
Reactions Weekly, 2021, 1853 (1) : 140 - 140
[23] Afatinib/osimertinibDrug resistance and various toxicities: case report
Reactions Weekly, 2021, 1877 (1) : 17 - 17
[24] Icotinib/osimertinibDrug resistance and liver injury: case report
Reactions Weekly, 2019, 1757 (1) : 155 - 155
[25] Afatinib/icotinib/osimertinibDrug resistance and diarrhoea: case report
Reactions Weekly, 2019, 1767 (1) : 25 - 25
[26] Crizotinib/erlotinib/osimertinibDrug resistance, acne and anorexia: case report
Reactions Weekly, 2021, 1852 (1) : 144 - 144
[27] Afatinib/osimertinibDrug resistance, loss of appetite and nausea: case report
Reactions Weekly, 2022, 1921 (1) : 17 - 17
[28] Icotinib/osimertinibDrug resistance, intestinal haemorrhage and colitis: case report
Reactions Weekly, 2022, 1907 (1) : 246 - 246
[29] GefitinibAcquired resistance to gefitinib: case report
Reactions Weekly, 2019, 1756 (1) : 160 - 160
[30] Gefitinib/osimertinibDevelopment of resistance: case report
Reactions Weekly, 2018, 1692 (1) : 152 - 152

← 1 2 3 4 5 →